Product Datasheet
LOXL2 Antibody
Catalog Number: 49699
Technical:tech@swbio.com
Information:info@swbio.com
Description
- Swiss-Prot No.:
- Swiss-Prot#:Q9Y4K0
- Form of Antibody:
- 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
- Immunogen:
- Recombinant protein
- appl_detail:
- WB: 1:500-1:2,000
IHC: 1:50-1:100
ICC: 1:50-1:200
FC: 1:50-1:100
- other_names:
- LOR 2 antibody
LOR2 antibody
LOX L2 antibody
LOXL 2 antibody
LOXL2 antibody
LOXL2_HUMAN antibody
Lysyl oxidase homolog 2 antibody
Lysyl oxidase like 2 antibody
Lysyl oxidase like protein 2 an
- Purification:
- ProA affinity purified
- Applications:
- WB,ICC,IF,IHC,FC
- Background:
- Mediates the post-translational oxidative deamination of lysine residues on target proteins leading to the formation of deaminated lysine (allysine). When secreted in extracellular matrix, promotes cross-linking of extracellular matrix proteins by mediating oxidative deamination of peptidyl lysine residues in precursors to fibrous collagen and elastin. Acts as a regulator of sprouting angiogenesis, probably via collagen IV scaffolding. When nuclear, acts as a transcription corepressor and specifically mediates deamination of trimethylated 'Lys-4' of histone H3 (H3K4me3), a specific tag for epigenetic transcriptional activation. Involved in epithelial to mesenchymal transition (EMT) via interaction with SNAI1 and participates in repression of E-cadherin, probably by mediating deamination of histone H3. Also involved in E-cadherin repression following hypoxia, a hallmark of epithelial to mesenchymal transition believed to amplify tumor aggressiveness, suggesting that it may play a role in tumor progression. Acts as a regulator of chondrocyte differentiation, probably by regulating expression of factors that control chondrocyte differentiation.
© Signalway Biotechnology All Rights Reserved.